1 |
Abramson, S. B. and Attur, M. 2009. Developments in the scientific understanding of osteoarthritis. Arthritis Res. Ther. 11, 227.
DOI
|
2 |
D'Arcy, P., Ryan, B. A. and Brodin, B. 2009. Reactivation of p53 function in synovial sarcoma cells by inhibition of p53-HDM2 interaction. Cancer Lett. 275, 285-292.
DOI
|
3 |
Farahat, M. N., Yanni, G., Poston, R. and Panayi, G. S. 1993. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann. Rheum. Dis. 52, 870-875.
DOI
|
4 |
Fearon, U., Griosios, K., Fraser, A., Reece, R., Emery, P., Jones, P. F. and Veale, D. J. 2003. Angiopoietins, growth factors, and vascular morphology in early arthritis. J. Rheumatol. 30, 260-268.
|
5 |
Fox, D. A., Gizinski, A., Morgan, R. and Lundy, S. K. 2010. Cell-cell interactions in rheumatoid arthritis synovium. Rheum. Dis. Clin. North. Am. 36, 311-323.
DOI
|
6 |
Gruber, H. E., Ingram, J. A., Hoelscher, G. L., Zinchenko, N., Norton, H. J. and Hanley, E. N. Jr. 2009. Matrix metalloproteinase 28, a novel matrix metalloproteinase, is constitutively expressed in human intervertebral disc tissue and is present in matrix of more degenerated discs. Arthritis Res. Ther. 11, R184.
DOI
|
7 |
Kim, W. U., Kang, S. S., Yoo, S. A., Hong, K. H., Bae, D. G., Lee, M. S., Hong, S. W., Chae, C. B. and Cho, C. S. 2006. Interaction of Vascular Endothelial Growth Factor 165 with Neuropilin-1 Protects Rheumatoid Synoviocytes from Apoptotic Death by Regulating Bcl-2 Expression and Bax Translocation. J. Immunol. 177, 5727-5735.
DOI
|
8 |
Kunisch, E., Fuhrmann, R., Roth, A., Winter, R., Lungershausen, W. and Kinne, R. W. 2004. Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry. Ann. Rheum. Dis. 63, 774-784.
DOI
|
9 |
Lee, S. H. 2005. Role of synovial fibroblasts in rheumatoid arthritis. Hanyang Medical Reviews 25, 36-42.
|
10 |
Liu, H., Perlman, H., Hoffmann, A., Thimmapaya, B. and Richard, M. P. 2000. Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kB but not C/EBPb or c-Jun. J. Immunol. 165, 7199-7206.
DOI
|
11 |
Lundy, S. K., Sarkar, S., Tesmer, L. A. and Fox, D. A. 2007. Cells of the synovium in rheumatoid arthritis. T slynphocytes. Arthritis Res. Ther. 9, 202.
DOI
|
12 |
Singh, J., Arayssi, T., Duray, P. and Schumacher, H. 2004. Immunohistochemistry of normal human knee synovium: a quantitative study. Ann. Rheum. Dis. 63, 785-790.
DOI
ScienceOn
|
13 |
Myers, S. L., Flusser, D., Brandt, K. D. and Heck, D. A. 1992. Prevalence of cartilage shards in synovium and their association with synovitis in patients with early and endstage osteoarthritis. J. Rheumatol. 19, 1247-1251.
|
14 |
Nakano, K., Yamaoka, K., Hanami, K., Saito, K., Sasaguri, Y., Yanagihara, N., Tanaka, S., Katsuki, I., Matsushita, S. and Tanaka, Y. 2011. Dopamine induces IL-6-dependent IL-17 production via D1-like receptor on CD4 naive T cells and D1-like receptor antagonist SCH-23390 inhibits cartilage destruction in a human rheumatoid arthritis/SCID mouse chimera model. J. Immunol. 186, 3745-3752.
DOI
|
15 |
Pessler, F., Dai, L., Diaz-Torne, C., Gomez-Vaquero, C., Paessler, M. E., Zheng, D. H., Einhorn, E., Range, U., Scanzello, C. and Schumacher, H. R. 2008. The synovitis of ''on-inflammatory''orthopaedic arthropathies: a quantitative histological and immunohistochemical analysis. Ann. Rheum. Dis. 67, 1184-1187.
DOI
|
16 |
Smith, J. B. and Haynes, M. K. 2002. Rheumatoid arthritismolecular understanding. Ann. Intern. Med. 136, 908-912.
DOI
ScienceOn
|